George Farmer
Stock Analyst at Scotiabank
(3.20)
# 1,078
Out of 5,056 analysts
70
Total ratings
47.37%
Success rate
3.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMEA Biomea Fusion | Maintains: Sector Outperform | $30 → $10 | $1.10 | +813.24% | 4 | Aug 6, 2025 | |
| ACLX Arcellx | Maintains: Sector Outperform | $93 → $133 | $89.00 | +49.44% | 4 | Jul 31, 2025 | |
| INMB INmune Bio | Downgrades: Sector Underperform | $23 → $0.6 | $1.51 | -60.26% | 3 | Jul 1, 2025 | |
| URGN UroGen Pharma | Maintains: Sector Outperform | $23 → $47 | $25.41 | +85.00% | 1 | Jun 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Sector Perform | $16 → $17 | $16.70 | +1.80% | 4 | May 6, 2025 | |
| TARA Protara Therapeutics | Initiates: Sector Outperform | $12 | $6.61 | +81.68% | 1 | Apr 16, 2025 | |
| TPST Tempest Therapeutics | Downgrades: Sector Perform | $91 → $9 | $4.77 | +88.68% | 4 | Apr 10, 2025 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $62 → $41 | $28.81 | +42.31% | 4 | Feb 28, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Sector Outperform | $47 → $52 | $38.65 | +34.54% | 4 | Feb 27, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $78 → $80 | $52.63 | +52.02% | 8 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $244 → $224 | $168.20 | +33.17% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $102 | $36.26 | +181.30% | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $11.36 | -11.97% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Sector Outperform | $439 → $715 | $917.68 | -22.09% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $20 → $23 | $5.41 | +325.14% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $20 | $1.33 | +1,403.76% | 1 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $70 → $76 | $28.08 | +170.66% | 4 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.88 | +351.39% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $24.21 | +350.23% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $101.26 | -14.08% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $2.48 | +1,233.33% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $0.71 | +5,524.30% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $42.25 | -36.09% | 3 | May 6, 2020 |
Biomea Fusion
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $30 → $10
Current: $1.10
Upside: +813.24%
Arcellx
Jul 31, 2025
Maintains: Sector Outperform
Price Target: $93 → $133
Current: $89.00
Upside: +49.44%
INmune Bio
Jul 1, 2025
Downgrades: Sector Underperform
Price Target: $23 → $0.6
Current: $1.51
Upside: -60.26%
UroGen Pharma
Jun 13, 2025
Maintains: Sector Outperform
Price Target: $23 → $47
Current: $25.41
Upside: +85.00%
Syndax Pharmaceuticals
May 6, 2025
Maintains: Sector Perform
Price Target: $16 → $17
Current: $16.70
Upside: +1.80%
Protara Therapeutics
Apr 16, 2025
Initiates: Sector Outperform
Price Target: $12
Current: $6.61
Upside: +81.68%
Tempest Therapeutics
Apr 10, 2025
Downgrades: Sector Perform
Price Target: $91 → $9
Current: $4.77
Upside: +88.68%
Janux Therapeutics
Feb 28, 2025
Maintains: Sector Perform
Price Target: $62 → $41
Current: $28.81
Upside: +42.31%
NewAmsterdam Pharma Company
Feb 27, 2025
Maintains: Sector Outperform
Price Target: $47 → $52
Current: $38.65
Upside: +34.54%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Sector Perform
Price Target: $78 → $80
Current: $52.63
Upside: +52.02%
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $244 → $224
Current: $168.20
Upside: +33.17%
Feb 13, 2025
Initiates: Sector Outperform
Price Target: $102
Current: $36.26
Upside: +181.30%
Jan 8, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $11.36
Upside: -11.97%
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $917.68
Upside: -22.09%
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $5.41
Upside: +325.14%
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $1.33
Upside: +1,403.76%
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $28.08
Upside: +170.66%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.88
Upside: +351.39%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $24.21
Upside: +350.23%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $101.26
Upside: -14.08%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $2.48
Upside: +1,233.33%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $0.71
Upside: +5,524.30%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $42.25
Upside: -36.09%